Expression and characterization of biologically active human Fas ligand produced in CHO cells

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 23, Issue 3, 2003, Pages 189-202

  Zappitelli, Sabrina ^a   D'Alatri, Laura ^a   Ciucci, Alessandra ^a   Raucci, Giuseppe ^a   Faiella, Angela ^a   Gabrielli, Meri ^a   Parlani, Massimo ^a   Bressan, Alessandro ^a   Maggi, Carlo A ^a   Goso, Cristina ^a   Rotondaro, Luigi ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

Apoptosis; CD95 APO 1 Fas ligand; CHO cells; Mass spectrometry; Recombinant protein

Indexed keywords

FAS LIGAND; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION SYSTEM; NONHUMAN; OLIGOMERIZATION; PROTEIN ANALYSIS; PROTEIN PURIFICATION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; FAS LIGAND PROTEIN; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; QUALITY CONTROL; RECOMBINANT PROTEINS; TRANSFECTION;

ANIMALIA;

EID: 0037338205     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:23:3:189     Document Type: Article

References (22)

1. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
2. Nagata, S. and Golstein, P. (1995) The Fas death factor. Science 267, 1449-1456.
3. Maggi, C. A. (1998) Therapeutic opportunities from the pharmacological manipulation of the Fas system. Pharmacol Res. 38, 1-34.
4. Kawaguchi, S., Mineta, T., Ichinose, M., Shiraishi, T., and Tabuchi, K. (2000) Induction of apoptosis in glioma cells by recombinant human Fas ligand. Neurosurgery 46, 431-439.
5. Schneider, P., Holler, N., Bodmer, J. L., et al. (1998) Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187, 1205-1213.
6. Connolly, K., Cho, Y. H., Duan, R., et al. (2001) In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor. J. Pharmacol. Exp. Ther. 298, 25-33.
7. Orlinick, J. R., Elkon, K. B., and Chao, M. V. (1997) Separate domains of the human fas ligand dictate self-association and receptor binding. J. Biol. Chem. 272, 32221-32229.
8. Schneider, P., Bodmer, J. L., Holler, N., et al. (1997) Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J. Biol Chem. 272, 18827-18833.
9. Muller, K. P., Mariani, S. M., Matiba, B., Kyewski, B., and Krammer, P. H. (1995) Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand. Eur. J. Immunol. 25, 2996-2999.
10. Rensing-Ehl, A., Frei, K., Flury, R., et al. (1995) Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25, 2253-2258.
11. Mariani, S. M., Matiba, B., Sparna, T., and Krammer, P. H. (1996) Expression of biologically active mouse and human CD95/APO-1/Fas ligand in the baculovirus system. J. Immunol. Methods 193, 63-70.
12. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T., and Nagata, S. (1994) Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6, 1567-1574.
13. Rotondaro, L., Mazzanti, L., Mele, A., and Rovera, G. (1997) High-level expression of a cDNA for human granulocyte colony-stimulating factor in Chinese hamster ovary cells. Effect of 3′-noncoding sequences. Mol Biotechnol. 7, 231-240.
14. Hopp, T. P., Prickett, K. S., Price, V. L., et al. (1988) A short polypeptide marker sequence useful for recombinant protein identification and purification. Biotechnology 6, 1204-1210.
15. Urlaub, G. and Chasin, L. A. (1980) Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc. Natl. Acad. Sci. USA 77, 4216-4220.
16. Heukeshoven, J. and Dernick, R. (1985) Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 6, 103-112.
17. DeLean, A., Munson, P. J., and RodBard, D. (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235, E97-E102.
18. Fraser, M. J. (1992) The baculovirus-infected insect cell as a eukaryotic gene expression system. Curr. Top. Microbiol. Immunol. 158, 131-172.
19. Goochee, C. F. and Monica, T. (1990) Environmental effects on protein glycosylation. Biotechnology 8, 421-427.
20. Ichikawa, K., Yoshida-Kato, H., Ohtsuki, M., et al. (2000) A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity. Int. Immunol. 12, 555-562.
21. Tanaka, M., Suda, T., Takahashi, T., and Nagata, S. (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129-1135.
22. Miranker, A. D. (2000) Protein complexes and analysis of their assembly by mass spectrometry. Curr. Opin. Struct. Biol. 10, 601-606.